HOME >> BIOLOGY >> NEWS
Society of Nuclear Medicine to offer first $25,000 Mallinckrodt Seed Grant

e considered until a satisfactory summary of an earlier grant is received.

This grant may supplement--not duplicate--other financial support. It will not pay institutional overhead costs or indirect costs, and no salary support will be provided for a principal investigator or co-principal investigators. The grant will be limited to a time span of one year, and no extensions will be allowed. Grantees are expected to submit results of the research as an abstract for presentation at SNM's Annual Meeting and/or as a scientific manuscript to the Journal of Nuclear Medicine.

SNM's grants and awards program is funded by both the Education and Research Foundation for the Society of Nuclear Medicine and the SNM Technologist Section (SNMTS) Professional Development and Education Fund. This program provides research grants and fellowships, educational scholarships and recognition awards to researchers, young investigators and students in nuclear medicine, molecular imaging and nuclear medicine technology. The Education and Research Foundation for SNM has been supporting the molecular imaging/nuclear medicine community since its founding in 1969. The foundation's mission is to advance excellence in health care through education and research in molecular imaging/nuclear medicine by provision of grants and awards.

"Providing molecular imaging/nuclear medicine professionals with increased support for cutting-edge research is one of the major priorities of SNM and the foundation," said ERF President Michael D. Devous Sr., Ph.D. "We are thankful that Tyco Healthcare/Mallinckrodt came forward to help us on this venture," he added.

For more information about this grant and application materials or to learn more about SNM, the foundation or making a contribution, please contact Kathy Bates, SNM's director of development, via phone at 703-708-9000, ext. 1028, or via e-mail at kbates@snm.org. Information is poste
'"/>

Contact: Maryann Verrillo
mverrillo@snm.org
703-708-9000
Society of Nuclear Medicine
13-Apr-2005


Page: 1 2 3

Related biology news :

1. American Chemical Societys Weekly PressPac -- Aug. 8, 2007
2. American Chemical Society meets Aug. 19-23 in Boston
3. American Chemical Societys Weekly PressPac -- Aug. 1, 2007
4. American Chemical Societys Weekly PressPac -- July 25, 2007
5. American Chemical Societys Weekly PressPac -- July 18, 2007
6. American Chemical Societys Weekly PressPac -- July 11, 2007
7. Tips from the Journals of the American Society for Microbiology
8. American Chemical Societys Weekly PressPac -- June 27/July 3, 2007
9. Health Physics Society
10. American Chemical Societys Weekly PressPac -- June 20, 2007
11. WPI professor to represent American Mathematical Society at exhibition on science funding

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Society Nuclear Medicine offer first Mallinckrodt Seed Grant

(Date:7/13/2015)... 2015 NXT-ID, Inc. (NASDAQ: NXTD ) ... focused on the growing mobile commerce market, announced ... for BEHAVIORAL-DIRECTED AUTHENTIATION METHOD AND SYSTEM. ... secure method to make payments.  With this patent, ... with its groundbreaking voice-direct payment patent application, with ...
(Date:7/9/2015)... 2015  Unchained Labs just can,t get enough ... Avid Nano. Avid Nano designs, develops and manufactures ... Also today, Unchained Labs UNcaged the ... use protein sizing system. The pUNk is a ... size, size distribution, aggregation population and molecular weight. ...
(Date:7/8/2015)... , N.J. and NEW YORK , ... and Guidepoint today announced BD & ... healthcare companies with free access to Guidepoint,s expert network ... start-ups that are developing cutting-edge technologies to improve healthcare ... dedicated Guidepoint research manager, each start-up entrepreneur will be ...
Breaking Biology News(10 mins):NXT-ID Patents Behavior-Directed Payments 2NXT-ID Patents Behavior-Directed Payments 3NXT-ID Patents Behavior-Directed Payments 4Unchained Labs just can't get enough, acquires Avid Nano, rocks out the new pUNk! 2BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 2BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 3
(Date:7/30/2015)... , ... July 30, 2015 , ... ... advanced fluid applications and designed for continuous operation up to 1500 bar. The ... ensuring safety, efficiency, and preventing toxic contamination. , The Pony™ NS2006L homogenizer is ...
(Date:7/29/2015)... CER / 20% of sales) led the regional performance in the second quarter ... as solid contributions from Korea, India and ... / Africa (Q2 2015: +3% CER / ... Turkey and the United Kingdom . The Americas ... sales, on demand across all customer classes. The top seven emerging markets (Q2 ...
(Date:7/29/2015)... 29, 2015 Research ... addition of the "Global Biosimilars Market, 2015 ... The Global Biosimilars Market, 2015 - 2025, ... growing biosimilars market. With the blockbuster biologics losing ... costs, biosimilars are being viewed as viable substitutes ...
(Date:7/29/2015)... July 29, 2015  Indivior PLC (LON: INDV) today ... nasal spray was accepted and received Priority Review by ... treatment of opioid overdose. This naloxone nasal spray comes ... for optimal absorption into the nasal mucosa. 1 ... so individuals may be better equipped to help an ...
Breaking Biology Technology:GEA Announces the Pony™ NS2006L… a Self-contained, High Pressure Lab Homogenizer for Product Development Ensuring Maximum Efficiency and Safety 2QIAGEN Reports Results for Second Quarter and First Half of 2015 2QIAGEN Reports Results for Second Quarter and First Half of 2015 3QIAGEN Reports Results for Second Quarter and First Half of 2015 4QIAGEN Reports Results for Second Quarter and First Half of 2015 5QIAGEN Reports Results for Second Quarter and First Half of 2015 6QIAGEN Reports Results for Second Quarter and First Half of 2015 7QIAGEN Reports Results for Second Quarter and First Half of 2015 8QIAGEN Reports Results for Second Quarter and First Half of 2015 9QIAGEN Reports Results for Second Quarter and First Half of 2015 10Global Biosimilars Market to 2025: Monoclonal Antibodies (mAbs), Insulin, Interferons, G-CSF/ GM-CSF, Erythropoietins and Others 2Global Biosimilars Market to 2025: Monoclonal Antibodies (mAbs), Insulin, Interferons, G-CSF/ GM-CSF, Erythropoietins and Others 3Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 2Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 3Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 4Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 5
Cached News: